StockData

Regenerative Medical Technology Group Inc. (RMTG) stock

RMTGOTCRetail-Retail Stores, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 19, 2026Score 3/30
$0.04−0.00 (-5.76%)

Close on Oct 19, 2026Market cap $497.25KP/E –Yield –

Regenerative Medical Technology gross margin

Gross margin is gross profit as a percentage of revenue.

Regenerative Medical Technology's gross margin for the twelve months ending Jun 30, 2026 was 59.8%. For fiscal 2025 it was 55.1%, against 68.7% the year before. The highest annual figure on record is 83.6% in fiscal 2017.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202555.1%−13.6
FY2024Dec 31, 202468.7%−0.8
FY2023Dec 31, 202369.5%+12.2
FY2022Dec 31, 202257.3%+23.0
FY2021Dec 31, 202134.3%+14.1
FY2020Dec 31, 202020.2%+104.6
FY2019Dec 31, 2019-84.4%−48.1
FY2018Dec 31, 2018-36.4%−119.9
FY2017Dec 31, 201783.6%–

Quarterly gross margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2026Jun 30, 202664.1%+4.5
Q1 FY2026Mar 31, 202666.9%−2.3
Q4 FY2025Dec 31, 202549.6%−15.3
Q3 FY2025Sep 30, 202542.5%−33.3
Q2 FY2025Jun 30, 202559.6%−6.9
Q1 FY2025Mar 31, 202569.2%−0.5
Q4 FY2024Dec 31, 202464.9%−5.7
Q3 FY2024Sep 30, 202475.7%+6.1
Q2 FY2024Jun 30, 202466.4%−3.8
Q1 FY2024Mar 31, 202469.6%+1.4
Q4 FY2023Dec 31, 202370.6%+7.3
Q3 FY2023Sep 30, 202369.6%−2.4
Q2 FY2023Jun 30, 202370.2%+20.8
Q1 FY2023Mar 31, 202368.3%+32.7
Q4 FY2022Dec 31, 202263.4%+31.7
Q3 FY2022Sep 30, 202272.0%+25.7
Q2 FY2022Jun 30, 202249.4%+24.6
Q1 FY2022Mar 31, 202235.6%+268.5
Q4 FY2021Dec 31, 202131.7%+24.9
Q3 FY2021Sep 30, 202146.4%+31.2
Q2 FY2021Jun 30, 202124.8%−9.5
Q1 FY2021Mar 31, 2021-232.9%−225.8
Q4 FY2020Dec 31, 20206.8%−34.4
Q3 FY2020Sep 30, 202015.1%+269.4
Q2 FY2020Jun 30, 202034.3%+142.6
Q1 FY2020Mar 31, 2020-7.1%+24.8
Q4 FY2019Dec 31, 201941.2%+376.3
Q3 FY2019Sep 30, 2019-254.2%−296.4
Q2 FY2019Jun 30, 2019-108.3%−144.5
Q1 FY2019Mar 31, 2019-31.8%−106.5
Q4 FY2018Dec 31, 2018-335.1%–
Q3 FY2018Sep 30, 201842.2%–
Q2 FY2018Jun 30, 201836.2%–
Q1 FY2018Mar 31, 201874.7%–

More Regenerative Medical Technology figures

See a number that looks wrong?